Robert Doebele serves as Executive at Rain Therapeutics Inc., where they oversee executive responsibilities. Since joining the company, Robert Doebele has executed 6 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jan 23, 2026 involved receiving (via award) 230,000 shares valued at $0.
Robert Doebele currently holds 230,000 shares of Rain Therapeutics Inc. (RAIN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Robert Doebele has been a net neutral trader of RAIN stock. They have purchased $0 and sold $0 worth of shares.
Robert Doebele's most recent insider trade was on Jan 23, 2026, when they sold 230,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jul 6, 2022 | RAIN | $15.4K | Option Exercise | 3,890 | $3.95 | Discretionary |
| Apr 13, 2022 | RAIN | $11.8K | Option Exercise | 3,000 | $3.95 | Discretionary |
| Mar 31, 2022 | RAIN | $7.9K | Option Exercise | 2,000 | $3.95 | Discretionary |
| Apr 27, 2021 | RAIN | $0 | Conversion | 4,932 | $N/A | Discretionary |